2009
DOI: 10.1007/s12028-009-9317-6
|View full text |Cite
|
Sign up to set email alerts
|

Continuous Selective Intraarterial Infusion of Nimodipine for Therapy of Refractory Cerebral Vasospasm

Abstract: Selective continuous intraarterial nimodipine treatment for refractory cerebral vasospasm after aSAH seems feasible and may add to the endovascular therapeutic options. Appropriate monitoring technology is essential for further investigation of this novel technique.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
18
1
4

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(25 citation statements)
references
References 21 publications
2
18
1
4
Order By: Relevance
“…Amrinone [8], l-arginine [9], colforsin daropate hydrochloride [10], papaverine [11], verapamil [12], nicardipine [13], and nimodipine [14, 15] have been tested for their effect on vasospasm, but none have shown significant difference to the others.…”
Section: Introductionmentioning
confidence: 99%
“…Amrinone [8], l-arginine [9], colforsin daropate hydrochloride [10], papaverine [11], verapamil [12], nicardipine [13], and nimodipine [14, 15] have been tested for their effect on vasospasm, but none have shown significant difference to the others.…”
Section: Introductionmentioning
confidence: 99%
“…Günümüzde papaverin kullanımı daha yeni vazodilatörlere oranla daha kısıtlı şekilde olmaktadır. Bunlar haricinde silastazol ve sildenafil, hayvan deneylerinde oldukça fazla kullanılan iyileşmeyi hızlandırıcı ajanlardır (9)(10)(11)(12) .…”
Section: Discussionunclassified
“…Нет стандартизиро-ванных руководящих принципов для отбора па-циентов, начала и продолжительности процеду-ры, а также для выбора оптимальной дозировки нимодипина, высокая доза которого может вы-звать гипотонию и усугубить ишемию головного мозга [20,23,24,25,26]. Кроме того, отсутствуют убедительные доказательства безопасности фар-макопластики ангиоспазма нимодипином, т.к.…”
Section: помощь практическому врачуunclassified
“…Кроме того, отсутствуют убедительные доказательства безопасности фар-макопластики ангиоспазма нимодипином, т.к. все имеющиеся сообщения основаны на анализе небольших серий случаев в отсутствии рандоми-зированных исследований по данной проблеме [20,23,24,25,26].…”
Section: помощь практическому врачуunclassified